Iovance Biotherapeutics
Huma Khan is currently serving as the Regional Operations Director for ATC Cell Therapy Operations at Iovance Biotherapeutics, Inc. Huma previously held positions at Advocate Lutheran General Hospital as the Manager for the Bone Marrow Transplant and Cellular Therapy Program and as the Bone Marrow Transplant Program RN Coordinator. Prior to that, Huma worked as an Oncology RN at NorthShore University HealthSystem. Huma holds a Master of Science in Biotechnology and a Bachelor of Science in Biology/Biological Sciences, General from the University of Kota, as well as a MSN in Leadership and Management from North Park University.
This person is not in any offices
Iovance Biotherapeutics
6 followers
Iovance Biotherapeutics (NASDAQ: IOVA) aims to improve patient care for people living with cancer. Iovance is investigating T cell-based therapies, known as tumor infiltrating lymphocytes (TIL), which use a patient’s own immune cells to attack cancer.